WITN2050053 - Factors to be considered in the Selection of Hepatitis Reduced Products for Clinical Trial Evaluation of residual infectivity for Hepatitis Viruses - 11 Jul 1983
Factors to be considered in the Selection of Hepatitis Reduced Products for Clinical Trial Evaluation of residual infectivity for Hepatitis Viruses
Documents
WITN2050053 Factors to be considered in the Selection of Hepatitis Reduced Products for Clinical Trial Evaluation of residual infectivity for Hepatitis Viruses 11 Jul 1983